Angela Rofelty

2.2k total citations
8 papers, 157 citations indexed

About

Angela Rofelty is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Angela Rofelty has authored 8 papers receiving a total of 157 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 4 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Angela Rofelty's work include Acute Myeloid Leukemia Research (7 papers), Chronic Lymphocytic Leukemia Research (2 papers) and HIV/AIDS drug development and treatment (2 papers). Angela Rofelty is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Chronic Lymphocytic Leukemia Research (2 papers) and HIV/AIDS drug development and treatment (2 papers). Angela Rofelty collaborates with scholars based in United States, Switzerland and India. Angela Rofelty's co-authors include Jeffrey Tyner, Shannon K. McWeeney, David K. Edwards, Anupriya Agarwal, Marc Loriaux, Alisa Damnernsawad, Mara Rosenberg, Nicola Long, Kevin Watanabe‐Smith and Ted Laderas and has published in prestigious journals such as Blood, Cancer Research and Leukemia.

In The Last Decade

Angela Rofelty

8 papers receiving 156 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Angela Rofelty United States	5	88	65	53	35	26	8	157
Sanchari Bhattacharyya United States	2	72 0.8×	113 1.7×	67 1.3×	44 1.3×	29 1.1×	3	176
Stefanie Kreutmair Germany	9	40 0.5×	53 0.8×	88 1.7×	49 1.4×	17 0.7×	21	173
Nicola Long United States	7	54 0.6×	119 1.8×	85 1.6×	32 0.9×	48 1.8×	17	203
Lorenz Bastian Germany	7	80 0.9×	73 1.1×	86 1.6×	55 1.6×	29 1.1×	24	209
Monika Baehner Switzerland	6	70 0.8×	32 0.5×	67 1.3×	65 1.9×	11 0.4×	8	162
Corinna Albers Germany	7	23 0.3×	89 1.4×	92 1.7×	25 0.7×	42 1.6×	13	171
Kyle Ferchen United States	5	103 1.2×	79 1.2×	148 2.8×	30 0.9×	20 0.8×	9	237
Kathrin Hanke Germany	3	110 1.3×	73 1.1×	85 1.6×	53 1.5×	19 0.7×	4	209
Gianpietro Dotti United States	5	28 0.3×	39 0.6×	47 0.9×	46 1.3×	35 1.3×	9	121
Johanna Erbani Australia	5	74 0.8×	98 1.5×	91 1.7×	41 1.2×	32 1.2×	7	202

Countries citing papers authored by Angela Rofelty

Since Specialization

Citations

This map shows the geographic impact of Angela Rofelty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Rofelty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Rofelty more than expected).

Fields of papers citing papers by Angela Rofelty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Rofelty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Rofelty. The network helps show where Angela Rofelty may publish in the future.

Co-authorship network of co-authors of Angela Rofelty

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Rofelty. A scholar is included among the top collaborators of Angela Rofelty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Rofelty. Angela Rofelty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Edwards, David K., Kevin Watanabe‐Smith, Angela Rofelty, et al.. (2018). CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells. Blood. 133(6). 588–599. 82 indexed citations

2.

Edwards, David K., Hibery Ho, Christopher A. Eide, et al.. (2018). Targeting of colony-stimulating factor 1 receptor (CSF1R) in the CLL microenvironment yields antineoplastic activity in primary patient samples. Oncotarget. 9(37). 24576–24589. 37 indexed citations

3.

Zhang, Hongzheng, Anna Reister Schultz, Samuel B. Luty, et al.. (2017). Characterization of the leukemogenic potential of distal cytoplasmic CSF3R truncation and missense mutations. Leukemia. 31(12). 2752–2760. 20 indexed citations

4.

Edwards, David K., Nathalie Javidi‐Sharifi, Angela Rofelty, et al.. (2017). Abstract 1087: CPX-351 works synergistically in combination with FLT3 inhibitors against AML with FLT3-ITD. Cancer Research. 77(13_Supplement). 1087–1087. 5 indexed citations

5.

Zhang, Haijiao, Beth Wilmot, Daniel Bottomly, et al.. (2017). Abstract 2452: Detailed genomic characterization of CNL/aCML/MPN-U/CMML reveals disease subgroups that may benefit from rationally-designed combination therapies. Cancer Research. 77(13_Supplement). 2452–2452. 1 indexed citations

6.

Edwards, David K., Nathalie Javidi‐Sharifi, Angela Rofelty, et al.. (2016). Effective Combination of CPX-351 with FLT3 Inhibitors in AML Blasts Harboring the FLT3-ITD Mutation. Blood. 128(22). 5124–5124. 9 indexed citations

7.

Kurtz, Stephen E., Christopher A. Eide, Andy Kaempf, et al.. (2016). Identification of Effective Combinations of Targeted Drugs for Hematologic Malignancies. Blood. 128(22). 836–836. 1 indexed citations

8.

Edwards, David K., Angela Rofelty, Anupriya Agarwal, et al.. (2015). CSF1R Inhibition Targets AML Cells By Depleting Supportive Microenvironmental Signal from CD14+ Monocytes. Blood. 126(23). 3824–3824. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact